Stryker Corp (SYK) 96.45 $SYK
Stryker Q1 Earnings Beat, Revenues in Line; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 9:10AM CDT
Stryker Corporation (SYK) reported modest first-quarter 2015 earning results. Adjusted earnings per share (EPS) of $1.11 beat the Zacks Consensus Estimate by a couple of cents while net sales of $2.38 billion were almost in line with the mark
CAPR: 7.50 (+0.76), SRDX: 26.57 (+0.02), LMAT: 8.44 (-0.10), SYK: 96.45 (+1.74)
Stryker (SYK) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Wed Apr 22, 6:16AM CDT
The following Stryker (SYK) conference call took place on April 21, 2015, 04:30 PM ET. This is a transcript of that earnings call:
SYK: 96.45 (+1.74)
Stryker's (SYK) CEO Kevin Lobo Discusses Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Apr 21, 10:15PM CDT
SYK: 96.45 (+1.74)
Stryker Q1 EPS up 222%; CF Ops up 85%; EPS guidance raised
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 5:16PM CDT
SYK: 96.45 (+1.74)
Look for Shares of Stryker to Potentially Pullback after Yesterday's 1.46% Rise
Comtex SmarTrend(R) - Tue Apr 21, 4:59PM CDT
Stryker (NYSE:SYK) traded in a range yesterday that spanned from a low of $93.73 to a high of $94.81. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $93.54 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SYK: 96.45 (+1.74)
After Yesterday's Rally of 1.46% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Apr 21, 4:58PM CDT
Stryker (NYSE:SYK) traded in a range yesterday that spanned from a low of $93.73 to a high of $94.81. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $93.54 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SYK: 96.45 (+1.74)
Stryker beats by $0.03, revenue in-line
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 3:49PM CDT
SYK: 96.45 (+1.74)
Stryker beats 1Q profit forecasts
Automated Insights - Tue Apr 21, 3:27PM CDT
KALAMAZOO, Mich. (AP) _ Stryker Corp. (SYK) on Tuesday reported first-quarter profit of $224 million.
SYK: 96.45 (+1.74)
Stryker (SYK) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Apr 21, 3:25PM CDT
SYK: 96.45 (+1.74)
Stryker Reports First Quarter 2015 Results
Thomson Reuters ONE - Tue Apr 21, 3:01PM CDT
Kalamazoo, Michigan - April 21, 2015 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2015:
SYK: 96.45 (+1.74)
Stryker reports Q1 results after the close
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 12:34PM CDT
SYK: 96.45 (+1.74)
Asian Nerve Repair & Regeneration Market by Type, by Procedure - Analysis and Forecast to 2019
M2 - Tue Apr 21, 9:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/54h2rs/asian_nerve) has announced the addition of the "Asian Nerve Repair & Regeneration Market by Type (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), by Procedure (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) - Analysis and Forecast to 2019" report to their offering. The Asian nerve repair and regeneration market comprises various types of products that can be segmented into nerve repair by biomaterials and nerve repair by neurostimulation, of which Nerve repair by Neurostimulation holds the highest market share of 57%, followed by nerve repair by biomaterials with a market share of 43% . The Asian Nerve repair and regeneration market is projected to grow at a CAGR of 11.7% by 2019, which is driven by several factors such as technological advancements and an increasing number of neuro injuries that have provided a whole lot of growth opportunities for the market. In the Asian region, the maximum market share is held by Japan and China, due to the increasing diseases related to nerves such as Parkinson's and Epilepsy, as these are the major application areas for the devices , along with an increase in the population. All the same, nerve repair by neurostimulation is also widely used. The report focuses on in-depth growth analysis in terms of market values in the respective geography and the market share of various companies that excel in these areas. Technological advancements have been a major driving factor of the market, which has been deeply analysed and put through the reports. Due to this increasing demand, the government has also shown its support; however, certain stringent rules and regulations such as the implementation of taxes may hamper the growth of the market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Nerve Repair and Regeneration Market, By Type 6 Nerve Repair and Regeneration Market, By Geography 7 Nerve Repair and Regeneration : Competitive Landscape 8 Nerve Repair and Regeneration Market, By Company - Axogen, Inc. - Integra Lifesciences Holdings Corp. - Medtronic, Inc. - Polyganics - S.T Jude Medical - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/54...sian_nerve
MDT: 78.01 (+0.93), SYK: 96.45 (+1.74)
Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Apr 20, 4:35PM CDT
EWBC: 41.97 (-0.02), SMCI: 31.90 (-2.91), VMW: 90.97 (+5.57), NBR: 15.05 (+0.68), ZIXI: 4.27 (+0.14), ILMN: 190.04 (-9.27), MANH: 54.02 (-2.16), YHOO: 43.97 (-0.52), DFS: 57.89 (-1.37), ACE: 107.86 (-1.15), CMG: 641.23 (-51.29), VASC: 33.30 (+4.06), FTI: 40.56 (+2.83), IRBT: 32.21 (-1.00), ADTN: 16.61 (-1.92), YUM: 84.04 (+3.19), CREE: 32.36 (-3.04), INFN: 19.79 (-0.43), SYK: 96.45 (+1.74), URI: 95.79 (-2.11), IBKR: 34.58 (+2.18), CAMP: 20.87 (+4.19), BRCM: 46.18 (+2.20), AMGN: 169.10 (+0.64), HTS: 18.40 (-0.20), ISRG: 516.93 (-29.80), DLB: 41.18 (+3.06), PFPT: 58.45 (-0.45), FULT: 12.50 (+0.21)
Will Stryker (SYK) Disappoint Earnings Estimates in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 17, 1:00PM CDT
Stryker Corp. (SYK) is slated to release its first-quarter 2015 financials on Apr 21. Last quarter, the company missed the Zacks Consensus Estimate by 0.7%.
VRX: 206.93 (-3.92), LH: 126.26 (+0.35), CGNX: 50.62 (+0.48), SYK: 96.45 (+1.74)
Osiris Therapeutics Announces First Quarter 2015 Financial Results Conference Call
Business Wire - Fri Apr 17, 7:00AM CDT
Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for first quarter ended March 31, 2015, on Friday, May 8, 2015. Lode Debrabandere, Ph.D., President and Chief Executive Officer, and Philip R. Jacoby, Jr., Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Friday, May 8, 2015, at 9:00 a.m. ET.
OSIR: 16.35 (-0.10), SYK: 96.45 (+1.74)
Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report Featuring Market Leaders, Agfa Finance, Direct Capital, De Lage Landen International, GE Healthcare & Hill-Rom
M2 - Fri Apr 17, 4:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9f8tq4/medical_equipment) has announced the addition of the "Medical Equipment Rental and Leasing - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Medical Equipment Rental and Leasing in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 103 companies including many key and niche players such as: - Agfa Finance Corp. (USA) - Direct Capital Corp. (USA) - De Lage Landen International B.V. (The Netherlands) - GE Healthcare Financial Services (USA) - Hill-Rom Holdings, Inc. (USA) - IBJ Leasing Company Ltd. (Japan) - National Technology Leasing Corp. (USA) - Oak Leasing Ltd (UK) - Prudential Leasing, Inc. (USA) - Rotech Healthcare, Inc. (USA) - Siemens Financial Services (Germany) - Stryker Corporation (USA) - Universal Hospital Services, Inc. (USA) Key Topics Covered: 1. MARKET OVERVIEW 2. GLOBAL HEALTHCARE SPENDING 3. AN INSIGHT INTO MEDICAL EQUIPMENT RENTAL AND LEASING 4. RECENT INDUSTRY ACTIVITY 5. FOCUS ON SELECT MARKET PLAYERS 6. GLOBAL MARKET PERSPECTIVE For more information visit http://www.researchandmarkets.com/research/9f..._equipment
HRC: 52.01 (+0.29), SYK: 96.45 (+1.74)
Global Minimal Invasive Device Market Outlook 2020
M2 - Thu Apr 16, 6:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tnb83x/global_minimal) has announced the addition of the "Global Minimal Invasive Device Market Outlook 2020" report to their offering. The market for minimally invasive medical devices has reached US$ 15 Billion in 2014. In the latest edition Global Minimally Invasive Device Market Outlook 2020, analysts have studied the dynamics of minimally invasive medical industry comprehensively. The report provides information on the current scenario, market segmentation on the basis of surgical devices and geography, and future estimations till 2020. The report also covers major factors propelling the growth of the industry, the regulatory framework, challenges holding back the industry, latest trends and developments, and mergers & acquisitions that have taken place in the past two years. The industry is facing cut-throat competition with the presence of existing as well as emerging players. The market is dominated by the US based medical robot manufacturer, Intuitive Surgical, with other notable players being GE Healthcare and Siemens Healthcare. Finally, to understand transparency of the existing competition, a separate section is devoted to the Porter's five forces model. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the minimally invasive market. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. A Brief Overview 4. Drivers 5. Challenges 6. Market Overview 7. Regulatory Landscape 8. Market Trends and Developments 9. Mergers & Acquisitions 10. Competitive Landscape 11. Porter's Five Forces Analysis Companies Mentioned - Intuitive Surgical - Medtronic Inc - Stryker Corporation - Boston Scientific - GE Healthcare - Covidien - Siemens Healthcare - Philip Healthcare - Johnson & Johnson For more information visit http://www.researchandmarkets.com/research/tn...al_minimal
ISRG: 516.93 (-29.80), BSX: 18.41 (+0.10), JNJ: 100.43 (+0.13), MDT: 78.01 (+0.93), SYK: 96.45 (+1.74)
OMNI Announces the Appointment of Steven Nunes as Senior Vice President of Sales and Marketing
PR Newswire - Wed Apr 15, 9:05AM CDT
OMNIlife science, Inc. ("OMNI"
, is an established medical technology company targeting the $15 billion and rapidly growing global hip and knee replacement medical device sector. They proudly offer the only commercially available surgical robotic system to enhance the surgeon's implant placement for total knee replacements, the OMNINAV(TM). Today OMNI announces that Steven Nunes has been appointed Senior Vice President of Sales and Marketing. In this expanded role, Mr. Nunes will also be responsible for Global Sales and Product Marketing Management in addition to the Robotics Market Development responsibilities he has been managing.
SYK: 96.45 (+1.74)
Osiris Therapeutics Announces Alla Danilkovitch, Ph.D., as Chief Scientific Officer
Business Wire - Thu Apr 09, 7:00AM CDT
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedic and sports medicine markets is pleased to announce the promotion of Alla Danilkovitch, Ph.D., to serve as Chief Scientific Officer.
OSIR: 16.35 (-0.10), SYK: 96.45 (+1.74)
Healthcare ratings roundup
Seeking Alpha - at Seeking Alpha - Wed Apr 08, 12:38PM CDT
IPXL: 49.58 (-0.40), CTRX: 59.46 (-0.11), OVAS: 29.85 (-0.24), AKRX: 53.70 (-1.69), CYTX: 0.96 (-0.09), NLNK: 53.12 (-0.07), MYL: 72.40 (-1.67), SGNT: 25.43 (-0.29), SYK: 96.45 (+1.74)
Stryker Q1 Earnings Beat, Revenues in Line; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 9:10AM CDT
Stryker Corporation (SYK) reported modest first-quarter 2015 earning results. Adjusted earnings per share (EPS) of $1.11 beat the Zacks Consensus Estimate by a couple of cents while net sales of $2.38 billion were almost in line with the mark
CAPR: 7.50 (+0.76), SRDX: 26.57 (+0.02), LMAT: 8.44 (-0.10), SYK: 96.45 (+1.74)
Stryker (SYK) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Wed Apr 22, 6:16AM CDT
The following Stryker (SYK) conference call took place on April 21, 2015, 04:30 PM ET. This is a transcript of that earnings call:
SYK: 96.45 (+1.74)
Stryker's (SYK) CEO Kevin Lobo Discusses Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Apr 21, 10:15PM CDT
SYK: 96.45 (+1.74)
Stryker Q1 EPS up 222%; CF Ops up 85%; EPS guidance raised
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 5:16PM CDT
SYK: 96.45 (+1.74)
Look for Shares of Stryker to Potentially Pullback after Yesterday's 1.46% Rise
Comtex SmarTrend(R) - Tue Apr 21, 4:59PM CDT
Stryker (NYSE:SYK) traded in a range yesterday that spanned from a low of $93.73 to a high of $94.81. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $93.54 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SYK: 96.45 (+1.74)
After Yesterday's Rally of 1.46% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Apr 21, 4:58PM CDT
Stryker (NYSE:SYK) traded in a range yesterday that spanned from a low of $93.73 to a high of $94.81. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $93.54 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SYK: 96.45 (+1.74)
Stryker beats by $0.03, revenue in-line
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 3:49PM CDT
SYK: 96.45 (+1.74)
Stryker beats 1Q profit forecasts
Automated Insights - Tue Apr 21, 3:27PM CDT
KALAMAZOO, Mich. (AP) _ Stryker Corp. (SYK) on Tuesday reported first-quarter profit of $224 million.
SYK: 96.45 (+1.74)
Stryker (SYK) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Apr 21, 3:25PM CDT
SYK: 96.45 (+1.74)
Stryker Reports First Quarter 2015 Results
Thomson Reuters ONE - Tue Apr 21, 3:01PM CDT
Kalamazoo, Michigan - April 21, 2015 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2015:
SYK: 96.45 (+1.74)
Stryker reports Q1 results after the close
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 12:34PM CDT
SYK: 96.45 (+1.74)
Asian Nerve Repair & Regeneration Market by Type, by Procedure - Analysis and Forecast to 2019
M2 - Tue Apr 21, 9:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/54h2rs/asian_nerve) has announced the addition of the "Asian Nerve Repair & Regeneration Market by Type (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), by Procedure (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) - Analysis and Forecast to 2019" report to their offering. The Asian nerve repair and regeneration market comprises various types of products that can be segmented into nerve repair by biomaterials and nerve repair by neurostimulation, of which Nerve repair by Neurostimulation holds the highest market share of 57%, followed by nerve repair by biomaterials with a market share of 43% . The Asian Nerve repair and regeneration market is projected to grow at a CAGR of 11.7% by 2019, which is driven by several factors such as technological advancements and an increasing number of neuro injuries that have provided a whole lot of growth opportunities for the market. In the Asian region, the maximum market share is held by Japan and China, due to the increasing diseases related to nerves such as Parkinson's and Epilepsy, as these are the major application areas for the devices , along with an increase in the population. All the same, nerve repair by neurostimulation is also widely used. The report focuses on in-depth growth analysis in terms of market values in the respective geography and the market share of various companies that excel in these areas. Technological advancements have been a major driving factor of the market, which has been deeply analysed and put through the reports. Due to this increasing demand, the government has also shown its support; however, certain stringent rules and regulations such as the implementation of taxes may hamper the growth of the market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Nerve Repair and Regeneration Market, By Type 6 Nerve Repair and Regeneration Market, By Geography 7 Nerve Repair and Regeneration : Competitive Landscape 8 Nerve Repair and Regeneration Market, By Company - Axogen, Inc. - Integra Lifesciences Holdings Corp. - Medtronic, Inc. - Polyganics - S.T Jude Medical - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/54...sian_nerve
MDT: 78.01 (+0.93), SYK: 96.45 (+1.74)
Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Apr 20, 4:35PM CDT
EWBC: 41.97 (-0.02), SMCI: 31.90 (-2.91), VMW: 90.97 (+5.57), NBR: 15.05 (+0.68), ZIXI: 4.27 (+0.14), ILMN: 190.04 (-9.27), MANH: 54.02 (-2.16), YHOO: 43.97 (-0.52), DFS: 57.89 (-1.37), ACE: 107.86 (-1.15), CMG: 641.23 (-51.29), VASC: 33.30 (+4.06), FTI: 40.56 (+2.83), IRBT: 32.21 (-1.00), ADTN: 16.61 (-1.92), YUM: 84.04 (+3.19), CREE: 32.36 (-3.04), INFN: 19.79 (-0.43), SYK: 96.45 (+1.74), URI: 95.79 (-2.11), IBKR: 34.58 (+2.18), CAMP: 20.87 (+4.19), BRCM: 46.18 (+2.20), AMGN: 169.10 (+0.64), HTS: 18.40 (-0.20), ISRG: 516.93 (-29.80), DLB: 41.18 (+3.06), PFPT: 58.45 (-0.45), FULT: 12.50 (+0.21)
Will Stryker (SYK) Disappoint Earnings Estimates in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 17, 1:00PM CDT
Stryker Corp. (SYK) is slated to release its first-quarter 2015 financials on Apr 21. Last quarter, the company missed the Zacks Consensus Estimate by 0.7%.
VRX: 206.93 (-3.92), LH: 126.26 (+0.35), CGNX: 50.62 (+0.48), SYK: 96.45 (+1.74)
Osiris Therapeutics Announces First Quarter 2015 Financial Results Conference Call
Business Wire - Fri Apr 17, 7:00AM CDT
Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for first quarter ended March 31, 2015, on Friday, May 8, 2015. Lode Debrabandere, Ph.D., President and Chief Executive Officer, and Philip R. Jacoby, Jr., Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Friday, May 8, 2015, at 9:00 a.m. ET.
OSIR: 16.35 (-0.10), SYK: 96.45 (+1.74)
Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report Featuring Market Leaders, Agfa Finance, Direct Capital, De Lage Landen International, GE Healthcare & Hill-Rom
M2 - Fri Apr 17, 4:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9f8tq4/medical_equipment) has announced the addition of the "Medical Equipment Rental and Leasing - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Medical Equipment Rental and Leasing in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 103 companies including many key and niche players such as: - Agfa Finance Corp. (USA) - Direct Capital Corp. (USA) - De Lage Landen International B.V. (The Netherlands) - GE Healthcare Financial Services (USA) - Hill-Rom Holdings, Inc. (USA) - IBJ Leasing Company Ltd. (Japan) - National Technology Leasing Corp. (USA) - Oak Leasing Ltd (UK) - Prudential Leasing, Inc. (USA) - Rotech Healthcare, Inc. (USA) - Siemens Financial Services (Germany) - Stryker Corporation (USA) - Universal Hospital Services, Inc. (USA) Key Topics Covered: 1. MARKET OVERVIEW 2. GLOBAL HEALTHCARE SPENDING 3. AN INSIGHT INTO MEDICAL EQUIPMENT RENTAL AND LEASING 4. RECENT INDUSTRY ACTIVITY 5. FOCUS ON SELECT MARKET PLAYERS 6. GLOBAL MARKET PERSPECTIVE For more information visit http://www.researchandmarkets.com/research/9f..._equipment
HRC: 52.01 (+0.29), SYK: 96.45 (+1.74)
Global Minimal Invasive Device Market Outlook 2020
M2 - Thu Apr 16, 6:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tnb83x/global_minimal) has announced the addition of the "Global Minimal Invasive Device Market Outlook 2020" report to their offering. The market for minimally invasive medical devices has reached US$ 15 Billion in 2014. In the latest edition Global Minimally Invasive Device Market Outlook 2020, analysts have studied the dynamics of minimally invasive medical industry comprehensively. The report provides information on the current scenario, market segmentation on the basis of surgical devices and geography, and future estimations till 2020. The report also covers major factors propelling the growth of the industry, the regulatory framework, challenges holding back the industry, latest trends and developments, and mergers & acquisitions that have taken place in the past two years. The industry is facing cut-throat competition with the presence of existing as well as emerging players. The market is dominated by the US based medical robot manufacturer, Intuitive Surgical, with other notable players being GE Healthcare and Siemens Healthcare. Finally, to understand transparency of the existing competition, a separate section is devoted to the Porter's five forces model. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the minimally invasive market. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. A Brief Overview 4. Drivers 5. Challenges 6. Market Overview 7. Regulatory Landscape 8. Market Trends and Developments 9. Mergers & Acquisitions 10. Competitive Landscape 11. Porter's Five Forces Analysis Companies Mentioned - Intuitive Surgical - Medtronic Inc - Stryker Corporation - Boston Scientific - GE Healthcare - Covidien - Siemens Healthcare - Philip Healthcare - Johnson & Johnson For more information visit http://www.researchandmarkets.com/research/tn...al_minimal
ISRG: 516.93 (-29.80), BSX: 18.41 (+0.10), JNJ: 100.43 (+0.13), MDT: 78.01 (+0.93), SYK: 96.45 (+1.74)
OMNI Announces the Appointment of Steven Nunes as Senior Vice President of Sales and Marketing
PR Newswire - Wed Apr 15, 9:05AM CDT
OMNIlife science, Inc. ("OMNI"
, is an established medical technology company targeting the $15 billion and rapidly growing global hip and knee replacement medical device sector. They proudly offer the only commercially available surgical robotic system to enhance the surgeon's implant placement for total knee replacements, the OMNINAV(TM). Today OMNI announces that Steven Nunes has been appointed Senior Vice President of Sales and Marketing. In this expanded role, Mr. Nunes will also be responsible for Global Sales and Product Marketing Management in addition to the Robotics Market Development responsibilities he has been managing. SYK: 96.45 (+1.74)
Osiris Therapeutics Announces Alla Danilkovitch, Ph.D., as Chief Scientific Officer
Business Wire - Thu Apr 09, 7:00AM CDT
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedic and sports medicine markets is pleased to announce the promotion of Alla Danilkovitch, Ph.D., to serve as Chief Scientific Officer.
OSIR: 16.35 (-0.10), SYK: 96.45 (+1.74)
Healthcare ratings roundup
Seeking Alpha - at Seeking Alpha - Wed Apr 08, 12:38PM CDT
IPXL: 49.58 (-0.40), CTRX: 59.46 (-0.11), OVAS: 29.85 (-0.24), AKRX: 53.70 (-1.69), CYTX: 0.96 (-0.09), NLNK: 53.12 (-0.07), MYL: 72.40 (-1.67), SGNT: 25.43 (-0.29), SYK: 96.45 (+1.74)
